SIOX logo

Sio Gene Therapies Inc



+ $0.09 (22.88%) This month

Closed: 7 Feb 2024 21:00 US/Eastern

Key details


Pavan Cheruvu




11 12 St Jamess Square, United Kingdom




Pharmaceutical Preparation Manufacturing

About Sio Gene Therapies Inc

axovant develops transformative gene therapies for patients with life-altering neurologic conditions. our mission is to identify, develop, and bring to market high-impact therapies that have the potential to improve the lives of patients with neurological disorders. our team is made up of leading scientific experts who are passionate about treating neurological conditions and easing the burden of these life-changing disorders for both patients and caregivers. our team is motivated by the promise of novel drug development, and is driven to find more efficient and effective ways to conduct scientific and clinical evaluations that rapidly deliver impactful medicines to patients in need. our leadership team has a track record bringing innovative new neurotherapeutic treatments to a global market, and along with our seasoned board of directors, is fully committed to the responsible pursuit of transformative therapies for some of the world's most difficult conditions.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG